A sponsor-open, randomized, placebo-controlled, phase I study to investigate the pharmacokinetics, safety, and tolerability of RO7223280 in healthy Chinese participants following single IV dose administration
Infectious Diseases
For the latest version of this information please go to www.forpatients.roche.com